Article

Clinician plays critical role in diagnosis, treatment of painful ophthalmoplegia

Chicago-Painful ophthalmoplegia may be a benign condition, such as microvascular ocular motor neuropathy, most commonly seen in the elderly with head and/or face pain, not requiring neuroimaging. On the other hand, it may be more serious with a combination of signs/symptoms that indicate a problem originating in the brain stem, cavernous sinus, or elsewhere, requiring a complete work-up, explained Gregory P. Van Stavern, MD.

"When someone comes in with painful diplopia, our job [as clinicians] is to put together their signs and symptoms and see if we can point to somewhere in the brain," said Dr. Van Stavern, assistant professor of ophthalmology and neurology, Kresge Eye Institute/Wayne State University, Detroit. "Physicians have to take a good history and at least be aware of some of the relevant neuro-anatomy."

During the Neuro-Ophthalmology Subspecialty Day Meeting at the American Academy of Ophthalmology annual meeting, Dr. Van Stavern covered four possible diagnoses of painful ophthalmoplegia: microvascular ocular motor neuropathy, pituitary apoplexy, carotid-cavernous fistulas, and cavernous sinus syndrome.

A 67-year-old man who had diabetes, hypertension, and painful diplopia existing for 2 weeks before presentation was examined at Dr. Van Stavern's clinic. On examination, a complete right abduction defect was found and there were no other localizing symptoms. A microvascular sixth nerve palsy was diagnosed and the patient did not require neuroimaging.

"It can be considered as a default diagnosis or diagnosis of exclusion," Dr. Van Stavern said.

In most of these cases, patients will recover over 3 to 4 months. However, if there has been no resolution of symptoms in 1 month or the patient's condition has not resolved between 4 and 6 months, neuroimaging should be considered. The development of new, localizing symptoms also suggests the need for neuroimaging, he said.

An emergency

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.